120 related articles for article (PubMed ID: 28730685)
1. TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.
Lin X; Chen Z; Gao P; Gao Z; Chen H; Qi J; Liu F; Ye D; Jiang H; Na R; Yu H; Shi R; Lu D; Zheng SL; Mo Z; Sun Y; Ding Q; Xu J
Prostate; 2017 Sep; 77(12):1271-1278. PubMed ID: 28730685
[TBL] [Abstract][Full Text] [Related]
2. Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
Wang M; Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Yin C; Zhang Z; Xu J
Carcinogenesis; 2012 Feb; 33(2):356-60. PubMed ID: 22114074
[TBL] [Abstract][Full Text] [Related]
3. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
Scarbrough PM; Weber RP; Iversen ES; Brhane Y; Amos CI; Kraft P; Hung RJ; Sellers TA; Witte JS; Pharoah P; Henderson BE; Gruber SB; Hunter DJ; Garber JE; Joshi AD; McDonnell K; Easton DF; Eeles R; Kote-Jarai Z; Muir K; Doherty JA; Schildkraut JM
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):193-200. PubMed ID: 26637267
[TBL] [Abstract][Full Text] [Related]
4. Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans.
Koboldt DC; Kanchi KL; Gui B; Larson DE; Fulton RS; Isaacs WB; Kraja A; Borecki IB; Jia L; Wilson RK; Mardis ER; Kibel AS
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1456-1463. PubMed ID: 27486019
[TBL] [Abstract][Full Text] [Related]
5. Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Mijuskovic M; Saunders EJ; Leongamornlert DA; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Govindasami K; Brook MN; Haiman CA; Conti DV; Eeles RA; Kote-Jarai Z
Br J Cancer; 2018 Jul; 119(1):96-104. PubMed ID: 29915322
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
7. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population.
Mandal RK; Kapoor R; Mittal RD
DNA Cell Biol; 2010 Nov; 29(11):669-74. PubMed ID: 20590474
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer.
Zhang XJ; Liu P; Zhu F
Genet Mol Res; 2014 Jan; 13(2):4419-24. PubMed ID: 24615090
[TBL] [Abstract][Full Text] [Related]
11. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.
Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Wang M; Zhang Z; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Xu J
Cancer Sci; 2011 Oct; 102(10):1916-20. PubMed ID: 21756274
[TBL] [Abstract][Full Text] [Related]
12. Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.
Oh JJ; Lee SJ; Hwang JY; Kim D; Lee SE; Hong SK; Ho JN; Yoon S; Sung J; Kim WJ; Byun SS
Oncotarget; 2017 Jul; 8(27):43934-43943. PubMed ID: 28380453
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population.
Liu J; Liu J; Wei M; He Y; Liao B; Liao G; Li H; Huang J
DNA Cell Biol; 2012 Jul; 31(7):1296-302. PubMed ID: 22506892
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.
Wang M; Li Q; Gu C; Zhu Y; Yang Y; Wang J; Jin L; He J; Ye D; Wei Q
Oncotarget; 2017 Apr; 8(15):24362-24371. PubMed ID: 27974699
[TBL] [Abstract][Full Text] [Related]
15. Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men.
Chen M; Huang YC; Yang S; Hsu JM; Chang YH; Huang WJ; Chen YM
Prostate; 2010 Apr; 70(5):502-7. PubMed ID: 19908238
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chip.
Oh JJ; Park S; Lee SE; Hong SK; Lee S; Jo JK; Lee JK; Ho JN; Yoon S; Byun SS
Urol Oncol; 2015 Sep; 33(9):385.e7-13. PubMed ID: 26087972
[TBL] [Abstract][Full Text] [Related]
18. Profile of common prostate cancer risk variants in an unscreened Romanian population.
Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
[TBL] [Abstract][Full Text] [Related]
20. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
